Armistice Capital, LLC Prothena Corp Public LTD CO Transaction History
Armistice Capital, LLC
- $6.56 Billion
- Q1 2025
A detailed history of Armistice Capital, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Armistice Capital, LLC holds 2,196,000 shares of PRTA stock, worth $16 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
2,196,000
Previous 2,236,000
1.79%
Holding current value
$16 Million
Previous $31 Million
12.21%
% of portfolio
0.41%
Previous 0.44%
Shares
6 transactions
Others Institutions Holding PRTA
# of Institutions
187Shares Held
43.7MCall Options Held
251KPut Options Held
79.2K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$84.4 Million11.27% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$37.9 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$28.1 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.46MShares$25.2 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.66MShares$12.1 Million4.1% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $342M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...